It is my great pleasure to discuss China cross-border collaboration opportunity with the opinion leaders from China. For these who is considering China strategy, please join us and register here: https://lnkd.in/egxzYvNX Key discussion points include: 1. In addition to crowded PD1, Claudia 18.2 space, any other directions Chinese companies expect to pay attention to? 2. Will there be growing interests in pre-clinical assets? What type of pre-clinical assets may attract Chinese companies? 3. In the coming years, in terms of in-licensing efforts, would oncology still be actively pursuing after? In addition to oncology, what other therapeutic areas/indications Chinese companies will be looking into? S. Frank YanTom DuJun BaoJack WuChunlin Adam Zhao
S. Frank Yan’s Post
More Relevant Posts
-
We are privileged to announce a new partnership with Novo Nordisk, a global leader in treating diabetes, on a profound global health challenge. We will explore for the first time how modulating biomolecular condensates with condensate modifying drugs (c-mods) can reverse the course of insulin resistance and diabetes, a growing epidemic impacting half a billion people. The partnership of two scientific leaders brings together Novo Nordisk’s expertise in treating diabetes and metabolic diseases with Dewpoint’s groundbreaking discovery and AI technology platform. https://lnkd.in/e_q-38S5 #DiscoverDewpoint #condensates #biotechnology
-
-
We’re excited to announce our decision to advance CFT8919, a novel degrader of epidermal growth factor receptor (EGFR) in NSCLC, into IND-enabling studies. https://bit.ly/2RKCgEU
-
-
Watch our company overview to see what C4 Therapeutics is all about. The full video can be accessed in the Life section of our LinkedIn page. https://bit.ly/3cAIkXe
C4 Therapeutics - Corporate Overview
-
Today C4 Therapeutics announced FDA clearance of our investigational new drug application for CFT7455, an orally bioavailable MonoDAC targeting IKZF1/3 for hematologic malignancies https://bit.ly/38VOFLX #proteindegradation
-
-
我已加入 #职场人时间捐赠计划 ，为大学生提供职业指导。一次善举，也许就能让年轻人少走弯路。点击链接，和我一起成为领英职场导师，也欢迎需要帮助的同学们来和我聊聊： https://lnkd.in/gFCmNTk